Chellman G J, White R D, Norton R M, Bus J S
Toxicol Appl Pharmacol. 1986 Oct;86(1):93-104. doi: 10.1016/0041-008x(86)90402-3.
Previous data have demonstrated that methyl chloride (MeCl) is toxic to B6C3F1 mice under both acute and chronic exposure conditions, and that conjugation of MeCl with glutathione (GSH) is a key step in the metabolism of MeCl. This study examined the role of GSH in mediating the acute toxicity of MeCl to liver, kidney, and brain of male B6C3F1 mice. The lethal effects of a single 6-hr inhalation exposure of B6C3F1 males to 2500 ppm MeCl were completely prevented by pretreatment with the GSH synthesis inhibitor, L-buthionine-S,R-sulfoximine (4 mmol L-BSO/kg, ip 1.5 hr prior to MeCl exposure). GSH levels (measured as nonprotein sulfhydryl) in liver and kidney were depleted to 19 and 25% of control values, respectively, at the start of the exposure; the ratio of dead/exposed mice during the 18-hr postexposure declined from 14/15 mice to 0/10. Also, the LC50 for MeCl increased from 2200 to 3200 ppm in male mice pretreated with BSO. The hepatic toxicity of MeCl was detected by increased alanine aminotransferase (ALT) activities in serum 18 hr after a 6-hr exposure to 1500 ppm MeCl (2147 +/- 1327 IU/liter vs 46 +/- 6 in controls). Liver toxicity was inhibited when B6C3F1 males were depleted of GSH prior to MeCl exposure by BSO pretreatment (43 +/- 2), fasting (100 +/- 47), or injection of diethyl maleate (42 +/- 16). The effects of GSH depletion on MeCl toxicity to brain and kidney were determined in B6C3F1 males exposed to 1500 ppm MeCl 6 hr/day, 5 days/week for 2 weeks, with and without daily pretreatment with 2 mmol L-BSO/kg. This dose of BSO depleted hepatic and renal GSH by 28 and 60%, respectively, at the start of MeCl exposure. BSO-pretreated mice were protected from the central nervous system toxicity of MeCl, as assessed by microscopic examination of the granule cell layer of the cerebellum. BSO pretreatment also inhibited the renal toxicity of MeCl as measured by incorporation of [3H]thymidine ([3H]TdR) into renal DNA, an indicator of cell regeneration after cortical necrosis. [3H]TdR incorporation was 105 +/- 10,337 +/- 40, and 60 +/- 15 dpm/microgram DNA in nonexposed controls, MeCl, and MeCl + BSO treatment groups, respectively. These results indicate that GSH is an important component in the toxicity of MeCl to multiple organ systems in B6C3F1 mice. Reaction of MeCl with GSH appears to constitute a mechanism of toxication, contrary to the role usually proposed for GSH in detoxifying xenobiotics.
先前的数据表明,在急性和慢性暴露条件下,甲基氯(MeCl)对B6C3F1小鼠均具有毒性,且MeCl与谷胱甘肽(GSH)的结合是MeCl代谢的关键步骤。本研究考察了GSH在介导MeCl对雄性B6C3F1小鼠肝脏、肾脏和大脑急性毒性中的作用。用GSH合成抑制剂L-丁硫氨酸-S,R-亚砜亚胺(4 mmol L-BSO/kg,在MeCl暴露前1.5小时腹腔注射)预处理,可完全预防B6C3F1雄性小鼠单次6小时吸入2500 ppm MeCl的致死效应。暴露开始时,肝脏和肾脏中的GSH水平(以非蛋白巯基衡量)分别降至对照值的19%和25%;暴露后18小时内死亡/暴露小鼠的比例从14/15降至0/10。此外,用BSO预处理的雄性小鼠中,MeCl的半数致死浓度(LC50)从2200 ppm增加到3200 ppm。在暴露于1500 ppm MeCl 6小时后18小时,血清中丙氨酸转氨酶(ALT)活性升高,检测到MeCl的肝脏毒性(2147±1327 IU/升,而对照组为46±6)。当B6C3F1雄性小鼠在MeCl暴露前通过BSO预处理(43±2)、禁食(100±47)或注射马来酸二乙酯(42±16)使GSH耗竭时,肝脏毒性受到抑制。在每周5天、每天6小时暴露于1500 ppm MeCl、持续2周的B6C3F1雄性小鼠中,测定了GSH耗竭对MeCl对大脑和肾脏毒性的影响,一组每天用2 mmol L-BSO/kg预处理,另一组不进行预处理。在MeCl暴露开始时,该剂量的BSO分别使肝脏和肾脏中的GSH耗竭28%和60%。通过对小脑颗粒细胞层的显微镜检查评估,BSO预处理的小鼠免受MeCl的中枢神经系统毒性。BSO预处理还抑制了MeCl的肾脏毒性,这通过[3H]胸腺嘧啶核苷([3H]TdR)掺入肾脏DNA来衡量,这是皮质坏死细胞再生的指标。在未暴露的对照组、MeCl组和MeCl + BSO治疗组中,[3H]TdR掺入量分别为105±10、337±40和60±15 dpm/μg DNA。这些结果表明,GSH是MeCl对B6C3F1小鼠多器官系统毒性的重要组成部分。与GSH通常在解毒外源性物质中所起的作用相反,MeCl与GSH的反应似乎构成了一种中毒机制。